Impact of a mindfulness stress management program on stress, anxiety, depression and quality of life in women with polycystic ovary syndrome: A randomized controlled trial

Stress

Volumn 18, Issue 1, 2015, Pages 57-66

  Stefanaki, Charikleia ^a   Bacopoulou, Flora ^a   Livadas, Sarantis ^a   Kandaraki, Anna ^a   Karachalios, Athanasios ^a   Chrousos, George P ^a   Diamanti Kandarakis, Evanthia ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Anxiety; Depression; Mindfulness; Polycystic ovary syndrome; Quality of life; Stress management

Indexed keywords

ANTIANDROGEN; CORTICOSTEROID; HYDROCORTISONE; METFORMIN; ORAL CONTRACEPTIVE AGENT; BIOLOGICAL MARKER;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; ASSESSMENT OF HUMANS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CREDIBILITY EXPECTANCY QUESTIONNAIRE; DEPRESSION; DEPRESSION ANXIETY STRESS SCALE; FEMALE; GENERAL LIFE SATISFACTION QUESTIONNAIRE; HUMAN; LIFE SATISFACTION; MINDFULNESS; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PARALLEL DESIGN; PERCEIVED STRESS SCALE; PLACEBO EFFECT; POLYCYSTIC OVARY SYNDROME HEALTH RELATED QUALITY OF LIFE QUESTIONNAIRE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ROUTINE DAILY LIFE QUESTIONNAIRE; SALIVA LEVEL; STRESS; STRESS MANAGEMENT; ANXIETY; GREECE; MENTAL HEALTH; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PSYCHOLOGY; QUESTIONNAIRE; SALIVA; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; ANXIETY; BIOMARKERS; DEPRESSION; FEMALE; GREECE; HUMANS; HYDROCORTISONE; MENTAL HEALTH; MINDFULNESS; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE; SALIVA; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84923855108     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890.2014.974030     Document Type: Article

References (49)

1. Benson S, Arck PC, Tan S, Hahn S, Mann K, Rifaie N, Janssen OE, et al. (2009). Disturbed stress responses in women with polycystic ovary syndrome. Psychoneuroendocrinology 34(5):727-35
2. Bhasin MK DJ, Chang BH, Joseph MG, Denninger JW, Fricchione GL, Benson H, Libermann TA. (2013). Relaxation response induces temporal transcriptome changes in energy metabolism, insulin secretion and inflammatory pathways. PLoS One 8:e62817
3. Brand S, Holsboer-Trachsler E, Naranjo JR, Schmidt S. (2012). Influence of mindfulness practice on cortisol and sleep in long-term and shortterm meditators. Neuropsychobiology 65(3):109-18
4. Brewer JA WP, Gray JR, Tang YY, Weber J, Kober H. (2011). Meditation experience is associated with differences in default mode network activity and connectivity. Proc Natl Acad Sci USA 108(50): 20254-9
5. Briggs SR, Cheek JM. (1986). The role of factor analysis in the development and evaluation of personality scales. J Person 54(1): 106-48
6. Costello MF, Misso ML, Wong J, Hart R, Rombauts L, Melder A, Norman RJ, Teede HJ. (2012). The treatment of infertility in polycystic ovary syndrome: a brief update. Aust NZJ Obstet Gynaecol 52(4):400-3
7. Darviri C, Fouka G, Gnardellis C, Artemiadis AK, Tigani X, Alexopoulos EC. (2012). Determinants of self-rated health in a representative sample of a rural population: a cross-sectional study in Greece. Int J Environ Res Public Health 9(3):943-54
8. de Sa JC, Costa EC, da Silva E, Zuttin RS, da Silva EP, Lemos TM, De Azevedo GD. (2011). Analysis of heart rate variability in polycystic ovary syndrome. Gynecol Endocrinol 27(6):443-7
9. Devilly GJ, Borkovec TD. (2000). Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry 31(2):73-86
10. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. (1999). A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 84(11):4006-11
11. Diener E, Inglehart R, Tay L. (2012). Theory and validity of life satisfaction scales. Soc Indic Res 112(3):497-527
12. Dokras A. (2012). Mood and anxiety disorders in women with PCOS. Steroids 77(4):338-41
13. Fekedulegn DB, Andrew ME, Burchfiel CM, Violanti JM, Hartley TA, Charles LE, Miller DB. (2007). Area under the curve and other summary indicators of repeated waking cortisol measurements. Psychosom Med 69(7):651-9
14. Gold ESA, Hopper I, Herne D, Tansey G, Hulland C. (2010). Mindfulness-based stress reduction (MBSR) in primary school teachers. J Child Fam Stud 19:184-9
15. Henderson VP, Clemow L, Massion AO, Hurley TG, Druker S, Hebert JR. (2012). The effects of mindfulness-based stress reduction on psychosocial outcomes and quality of life in early-stage breast cancer patients: a randomized trial. Breast Cancer Res Treat 131(1): 99-109
16. Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. (2012). Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial. J Clin Oncol 30(12):1335-42
17. Hollis S, Campbell F. (1999). What is meant by intention to treat analysis?. Survey of published randomised controlled trials. BMJ 319(7211):670-4
18. Holzel BK, Carmody J, Vangel M, Congleton C, Yerramsetti SM, Gard T, Lazar SW. (2011). Mindfulness practice leads to increases in regional brain gray matter density. Psychiatry Res 191(1):36-43
19. Inder WJ, Dimeski G, Russell A. (2012). Measurement of salivary cortisol in 2012 - laboratory techniques and clinical indications. Clin Endocrinol (Oxf) 77(5):645-51
20. Izawa S, Sugaya N, Yamamoto R, Ogawa N, Nomura S. (2010). The cortisol awakening response and autonomic nervous system activity during nocturnal and early morning periods. Neuro Endocrinol Lett 31(5):685-9
21. Jones GL, Benes K, Clark TL, Denham R, Holder MG, Haynes TJ, Mulgrew NC, et al. (2004). The Polycystic Ovary Syndrome Health- Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod 19(2):371-7
22. Julious SA. (2005). Sample size of 12 per group rule of thumb for a pilot study. Pharmaceut Stat 4:287-91
23. Katsarou A, Panagiotakos D, Zafeiropoulou A, Vryonis M, Skoularigis I, Tryposkiadis F, Papageorgiou C. (2012). Validation of a Greek version of PSS-14; a global measure of perceived stress. Cent Eur J Public Health 20(2):104-9
24. Kerr CE, Sacchet MD, Lazar SW, Moore CI, Jones SR. (2013). Mindfulness starts with the body: somatosensory attention and topdown modulation of cortical alpha rhythms in mindfulness meditation. Front Hum Neurosci 7:12
25. Kilpatrick LA, Suyenobu BY, Smith SR, Bueller JA, Goodman T, Creswell JD, Tillisch K, Mayer EA, Naliboff BD. (2011). Impact of mindfulness-based stress reduction training on intrinsic brain connectivity. Neuroimage 56(1):290-8
26. Kirsch I. (2005). Placebo psychotherapy: synonym or oxymoron?. J Clin Psychol 61(7):791-803
27. Klainin-Yobas P, Cho MA, Creedy D. (2012). Efficacy of mindfulnessbased interventions on depressive symptoms among people with mental disorders: a meta-analysis. Int J Nurs Stud 49(1):109-21
28. Krepula K, Bidzinska-Speichert B, Lenarcik A, Tworowska-Bardzinska U. (2012). Psychiatric disorders related to polycystic ovary syndrome. Endokrynol Pol 63(6):488-91
29. Kubota Y, Sato W, Toichi M, Murai T, Okada T, Hayashi A, Sengoku A. (2001). Frontal midline theta rhythm is correlated with cardiac autonomic activities during the performance of an attention demanding meditation procedure. Brain Res Cogn Brain Res 11(2):281-7
30. Lansdown A, Rees DA. (2012). The sympathetic nervous system in polycystic ovary syndrome: a novel therapeutic target?. Clin Endocrinol (Oxf) 77(6):791-801
31. Lyrakos GN, Arvaniti C, Smyrnioti M, Kostopanagiotou G. (2011). Translation and validation study of the depression anxiety stress scale in the Greek general population and in a psychiatric patient's sample. Eur Psychiatry 26:1731
32. Mansson M, Norstrom K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Landen M. (2011). Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol 155(2):161-5
33. Milutinovic DV, Macut D, Bozic I, Nestorov J, Damjanovic S, Matic G. (2011). Hypothalamic-pituitary-adrenocortical axis hypersensitivity and glucocorticoid receptor expression and function in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes 119(10): 636-43
34. Paredes A, Gálvez A, Leyton V, Aravena G, Fiedler JL, Bustamante D, Lara HE. Stress promotes development of ovarian cysts in rats: the possible role of sympathetic nerve activation. Endocrine 1998;8:309-15
35. Piazza JR, Charles ST, Stawski RS, Almeida DM. (2013). Age and the association between negative affective states and diurnal cortisol. Psychol Aging 28(1):47-56
36. Praissman S. (2008). Mindfulness-based stress reduction: a literature review and clinician's guide. J Am Acad Nurse Pract 20(4):212-6
37. Pruessner JC, Kirschbaum C, Meinlschmid G, Hellhammer DH. (2003). Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28(7):916-31
38. Raja-Khan N, Stener-Victorin E, Wu X, Legro RS. (2011). The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. Am J Physiol Endocrinol Metab 301(1): E1-10
39. Robins CJ, Keng SL, Ekblad AG, Brantley JG. (2012). Effects of mindfulness-based stress reduction on emotional experience and expression: a randomized controlled trial. J Clin Psychol 68(1): 117-31
40. Rosenzweig S RD, Greeson JM, Edman JS, Jasser SA, McMearty KD, Goldstein BJ. (2007). Mindfulness-based stress reduction is associated with improved glycemic control in type 2 diabetes mellitus: a pilot study. Altern Ther Health Med 13:36-8
41. Roth LW, Huang H, Legro RS, Diamond MP, Coutifaris C, Carson SA, Steinkampf MP, et al. (2012). Altering hirsutism through ovulation induction in women with polycystic ovary syndrome. Obstet Gynecol 119(6):1151-6
42. Sim J, Lewis M. (2012). The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency. J Clin Epidemiol 65(3):301-8
43. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR. (2009). Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 338:b2393
44. Streiner DL, Norman GR. (1995). Health measurement scales: a practical guide to their development and use. 2nd ed. Oxford: Oxford University Press
45. Sundbom LT, Bingefors K. (2013). The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden. Patient Prefer Adherence 7:805-11
46. Takeuchi H, Taki Y, Nouchi R, Hashizume H, Sassa Y, Sekiguchi A, Kotozaki Y, et al. (2014). Anatomical correlates of quality of life: evidence from voxel-based morphometry. Hum Brain Mapp 35(5): 1834-46
47. Turakitwanakan W, Mekseepralard C, Busarakumtragul P. (2013). Effects of mindfulness meditation on serum cortisol of medical students. J Med Assoc Thai 96:S90-5
48. Van Cauter E1, Leproult R, Kupfer DJ. (1996). Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. J Clin Endocrinol Metab 81(7):2468-73
49. Yildirir A, Aybar F, Kabakci G, Yarali H, Oto A. (2006). Heart rate variability in young women with polycystic ovary syndrome. Ann Noninvasive Electrocardiol 11(4):306-12